1) Wegmann TG & Gill III TJ, eds:Immunology of Reproduction. Oxford University press, Oxford, UK, 1983.
2) Andreanii D, Bompiani G, DiMario U, Faulk WP and Galluzzo A, eds:Immunology of Normal and Diabetic pregnancy, Willy and Sons, Chichester, UK, 1990.
3) Redman CWG, et al:Immunological dosorders of human pregnancy. Oxford Rev Reprod Biol, 8:223, 1986.
6) 山本樹生, 他:妊娠中毒症における抗ラミニン抗体の検索. 日本臨床免疫学会雑誌, 14:9, 1991.
7) 稲葉憲之:自己免疫抗体および血清補体値による妊娠中毒症の発症予知. 産と婦, 11:2019, 1978.
8) Parke A, et al:Subclinical autoimmune diseases and recurrent spontaneous abortion. J Rheumatol, 13:1178, 1986.
10) MacQuarrie I:Apossible relationships between interaggultination and the toxemia ofpregnancy. Johns Hopkins Hosp Bull, 34:51, 1983.
13) 大野 乾:精巣の分化とHY抗原. 新生理学大系, 21巻, p.29, 医学書院, 1989.
15) Levanon Y, Rossetini SMO:Presence of circulating placental antigens and antibodies in toxemia and normal pregnancy patients. Zeit Immunitas, 178:186, 1968.
16) Gaugas JM, et al:Complement fixing antibody against solubilized placental microsomal fraction in preeclampsia sera. Br J Pathol, 55:570, 1974.
19) Ceretti N, et al:Association of anti HLA antibodies with toxemia in pregnancy, Immunology of Obstetrics and gynaecology (ed. A Cento). Excepta Medica, Holland, p231, 1974.
20) Harris RE and Lordon RE:The association of maternal lymphocytotoxic antibodies with obsteric complications. Obstet Gynecol, 48:302, 1976.
21) Jenkins DM, et al:Dificiency of specific HLA antibodies in severe pregnancy preeclampsia/eclampsia. Clin Exp Immunol, 27:485, 1977.
24) Nicola M, et al:Subclinical autoimmunity in EPH gestosis. Proc VII world congress of hypertension in pregnancy, p279, 1990.
25) Yamamoto T, et al:Anti-ssDNA and anti-dsDNA antibodies in preeclampsia. Proc Jpn Soc Reprod Immunol, p5, 1990.
26) 山本樹生, 他:妊娠中毒症における抗ラミニン抗体の検索. 日本臨床免疫学会雑誌, 14:9, 1991.
27) Yamamoto T, et al:Measurement of antiphospholipid antibody by ELISA using purified β2 glycoprotein I in preeclampsia. Clin Exp Immunol, 94:196-200, 1993.
31) Balash J, et al:Further evidence against preeclampsia as an immune complexes diseases, Obstet Gynecol, 58:435, 1981.
34) Schena FP, et al:Behaviour of immune complexes and the complement system in normal pregnancy and in preeclampsia. J Clin Exp Immunol, 7:21, 1982.
35) Stimson WH, et al:An assay for antigen-antibody complexes in human sera using C1q enzyme conjugate. J Clin Lab Immunol, 5:129, 1981.
36) Vasquez-Escobosa C, et al:Circulating immune complexes in hypertensive diseases of pregnancy. Obstet Gynecol, 62:45-48, 1985.
39) 山本樹牛:正常妊娠および中毒症における免疫複合体と好中球機能に関する研究. 日大医誌, 40:949, 1981.
40) 倉本雅規:妊婦血清中における免疫複合体の役割. 日産婦誌, 34:285, 1981.
41) D'Amelio E, et al:Circulating immune complexes in normal pregnant women and in some conditions complicating pregnancy. Clin Exp Immunol, 37:33, 1979.
43) 斉藤 滋:妊娠中毒症における血中免疫複合体および補体系の変動. 産婦世界, 36夏期増刊:108, 1984.
48) Tedder RS, et al:Effects on serum complements of normal and preeclampsia, pregnancy and oral contraceptives. Ge J Exp Pathol, 56:389, 1975.
50) Thompson NC, et al:Immunological studies in preeclamptic toxemia. Br Med J, 1:1307, 1978.
51) Mak LW:The complement profile in relation to the reactor state, a study in the immediate postpartum period. Clin Exp Immunol, 31:419, 1978.
52) 東 政弦,:晩期妊娠中毒症の本態に関する免疫学的-特に補体学的研究. 日産婦誌, 22:1127, 1970.
53) 山本樹生, 他:妊娠中毒症における免疫複合体と好中球機能. 産と婦, 34:285, 1982.
55) Howerd MA:Lupus anticoagulaht in women with multiple spontaneous miscarriage. Am J Haematol, 76:68, 1987.
57) Bransh DW:The association of antiphospholipid antibodies and severe preeclampsia. Obstet Gynecol, 73:541, 1989.
58) Walters J, et al:Anticardiolipin antibodies are associated with severe early onset preeclampsia and postpartum mobility including HELLP syndrome. Proc VII world congress of hypertension in pregnancy. p247, 1990.
60) Halbrecht IG, et al:Mixed wife-husband leucocyte cultures in disturbed andpathological pregnancies. Israel J Med Sci, 10 : 1100, 1974.
63) Jenkins DM, et al:Dificiency of specific HLA antibodies in severe preeclam-psia/eclampsia. Clin Exp Immunol, 27:485, 1977.
66) Bardeguez AD, et al:Cellular immunity in preeclampsia in T-lymphocyte subpopulations during early pregnancy. Obstet Gynecol, 77:859-862, 1991.
67) 田矢洋一, 野田 亮, 山本 雅:がん遺伝子ハンティング. 羊土社, 1990.
68) 早川 智, 他:癌遺伝子. 産と婦, 56:2409-2417, 1989.
70) Goyett M, et al:Regulated transcription of c-Kiras and c-myc during compensatory growth of rat liver. Science, 219:510-514, 1983.
74) Deguchi Y, et al:Protooncogene expression and nuclear factor specifically bound to cmyc gene in peripheral blood mononuclear cells from progressive systemic sclerosis patients as the indication of clinical activity. J Clin Lab Immunol, 26:163, 1988.
75) Bounpas DT, et al:c-myc oncogene expression in peripheral blood mononuclear cellsfrom patients with primary Sj6gren syndrome. Arth Rheumatol, 33:49, 1990.
76) Hayakawa S, et al:Increased expression of c-myc protooncogene in peripheral lymphocytes in the patients with preeclampsia. In Hypertension in pregnancy (ed Cosmi), Mondutti Editore, Milano, 1991.
77) 佐藤和雄, 他:妊娠中毒症と免疫. 産と婦, 53:1133-1144, 1986.
78) 千島史尚:リンパ球のc-myc発現とそれに及ぼす妊婦血清の影響-flow cytometry による解析. 日大医誌, 49:129, 1990.
79) 早川 智, 他:妊娠中毒症と細胞性免疫, HLA. 産婦世界, 45:477-483, 1993.
80) Hayakawa S, et al:Increased expression of c-myc protooncogene in peripheral lymphocytes in the patients with preeclampsia. In Hypertension in pregnancy (ed Cosmi), Mondutti Editore, Milano, 1991.
91) Hayakawa S, et al:Possible relationships between prevalence of fetal cellsin the maternal circulation and preeclampsia. (Submitted)
93) Alanen A and Lassila O:Dificient NK cells function in preclampsia. Obstet Gynecol, 60:631, 1982.
94) 山本樹生, 近藤泰正:妊娠中毒症における免疫学的考察. 妊娠中毒症の病態と管理, 同朋舎出版, 京都, p121, 1982.
95) Chishima F, et al:Changes in granulocyte surface markers, IgG, IgM and C3 in pregnancy and preeclampsia. Acta Wr world congress of hypertention in pregnancy. Mondutti Editore, Milano, 1992.
97) 飯島 悟, 他:好中球レオロジーと妊娠中毒症. 産婦世界, 45:485-494, 1993.
98) 秋山邦久:妊孕現象の移植免疫学的考察-特に食細胞の動態と流血中の免疫複合体について. 日大医誌, 47:1059, 1988.
99) 笠倉新平:妊娠における免疫の役割. 産婦世界, 45:449-456, 1993.
102) Saito S, Nishikawa K, Morii T, Narita N, Enomoto M & Ichijo M:Expression of activation antigens CD69, HLA-DR interleukin-2 receptor alpha (12Ra) and IL-2Rb on T-cells of human decidua at an early stage of pregnancy. Immunology, 75:710-712, 1992.
104) 斉藤 滋, 他:妊娠中毒症における免疫複合体, 補体, サイトカインの意義. 産婦世界, 45:477-483, 1993.
105) Fox H:Pathology of Placenta. Saunders, 1981.
109) 山本樹生, 他:免疫複合体と胎盤の病理形態的変化. 産婦世界, 36:116, 1983.
110) 井一夫:妊娠中毒における流血中免疫複合体と胎盤の変化について. 日大医誌, 49:787, 1990.
112) Faulk WP, et al:Immunological studies of human placentae; complement components in preeclamptic chorionic villi. Clin Exp Immunol, 27:485, 1984.
113) 高木繁夫, 他:妊娠中毒症と免疫. 産婦人科MOOK37, p248, 1987.
115) 藤多和義:妊娠中毒症における免疫学的検討. 日腎誌, 17:1, 1975.
119) Weinstein L:Discussion of the HELLP syndrome. 51th ANN Meet Central Ass Obstet Gynecol, Corolad Springs, 1983.
120) Weichert W:Zur Kentnis des heufirber und eklampsie bein serum. Wien Klin Wochenshr, 10:1945, 1903.
121) 馬杉復三, 富岡八十一:抗臓器血清による臓器の特異性変化の本態について, とくに Nephrotoxin および Hepatotoxin による腎および肝変化について. 付. 糸球体腎炎および子瘤肝の病理発生について. 千葉医誌, 9:114, 1931.